Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.17M Buy
22,268
+866
+4% +$45.8K 0.3% 90
2026
Q1
$1.18M Sell
21,402
-28
-0.1% -$1.52K 0.34% 88
2025
Q4
$1.05M Sell
21,430
-130
-0.6% -$6.06K 0.3% 93
2025
Q3
$931K Buy
21,560
+1,298
+6% +$50.7K 0.28% 96
2025
Q2
$778K Buy
+20,262
New +$774K 0.26% 104

Other funds holding GSK

LOM Asset Management's GSK Position: Q2 2026 in Review

LOM Asset Management increased its GSK (GSK) stake by 4% in Q2 2026, buying an estimated $45.8K and bringing the position to 22,268 shares worth $1.17M. The position accounts for 0.3% of the portfolio, ranked #90.

LOM Asset Management first reported a position in GSK in Q2 2025 and has held it in 5 quarters since. The position peaked at $1.18M in Q1 2026. 1,037 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • LOM Asset Management held 22,268 shares of GSK worth $1.17M as of Q2 2026.
  • LOM Asset Management bought 866 GSK shares in Q2 2026, an estimated $45.8K.
  • GSK made up 0.3% of LOM Asset Management's portfolio in Q2 2026, its #90 holding.
  • LOM Asset Management first reported a position in GSK in Q2 2025 and has held it in 5 quarters since.
  • LOM Asset Management's GSK position peaked at $1.18M in Q1 2026.
  • 1,037 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on LOM Asset Management's 13F filing for Q2 2026, filed 4 Aug 2026.